Ras P21 Expression in Relation to Histopathological Variables and Prognosis in Colorectal Adenocarcinoma

Authors

  • X-F. Sun Departments of Oncology, Pathology, and Surgery, University Hospital, Linköping, Sweden
  • T. Hatschek Departments of Oncology, Pathology, and Surgery, University Hospital, Linköping, Sweden
  • S. Wingren Departments of Oncology, Pathology, and Surgery, University Hospital, Linköping, Sweden
  • O. Stål Departments of Oncology, Pathology, and Surgery, University Hospital, Linköping, Sweden
  • J. M. Carstensen Departments of Oncology, Pathology, and Surgery, University Hospital, Linköping, Sweden
  • H. Zhang Departments of Oncology, Pathology, and Surgery, University Hospital, Linköping, Sweden
  • B. Boeryd Departments of Oncology, Pathology, and Surgery, University Hospital, Linköping, Sweden
  • R. Sjödahi Departments of Oncology, Pathology, and Surgery, University Hospital, Linköping, Sweden
  • B. Nordenskjöld Departments of Oncology, Pathology, and Surgery, University Hospital, Linköping, Sweden

DOI:

https://doi.org/10.3109/02841869109088246

Keywords:

Ras p21, histopathology, prognosis, colorectal adenocarcinoma, immunohistochemistry

Abstract

Ras gene protein products (p21) reacting with the monoclonal antibodies ras 11, DWP, R256 and El84 were studied with an immunohistochemical method which was applied to 17 normal and 79 colorectal adenocarcinoma specimens. Normal colorectal epithelium showed positive staining for ras 11 in 35% of the cases, but not for DWP, R256 and E184. The antibodies showed positive staining in colorectal adenocarcinomas in 76, 53, 29 and 35% of the cases respectively. The degree of staining for ras 11 was significantly related to the grade of differentiation and increased from Dukes stage A to C. Strong staining for ras 11 predicted a significantly shorter recurrence-free interval (p < 0.001). In Cox's regression analysis, the degree of staining for ras 11 was a prognostic factor independent of the grade of differentiation and Dukes stage (p<0.01). The results indicate that the enhanced expression of pan ras p21 may provide an important biological marker for determining prognosis in colorectal adenocarcinomas.

Downloads

Download data is not yet available.

Downloads

Published

1991-01-01

How to Cite

Sun, X.-F., Hatschek, T., Wingren, S., Stål, O., Carstensen, J. M., Zhang, H., … Nordenskjöld, B. (1991). Ras P21 Expression in Relation to Histopathological Variables and Prognosis in Colorectal Adenocarcinoma. Acta Oncologica, 30(8), 933–939. https://doi.org/10.3109/02841869109088246